Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.50 |
| ▸ | ERN1 | O75460 | 6/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | CASP7 | P55210 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL498578 | 0.87 | DPP4 (0.45) | DPP4ERN1KDM4EMAPTNPC1 | |
| SCHEMBL29839866 | 0.83 | ERN1 (0.47) | DPP4ERN1KDM4EMAPTNPC1 | |
| SCHEMBL975367 | 0.82 | DPP4 (0.39) | DPP4ERN1KDM4EMAPTNPC1 | |
| SCHEMBL499178 | 0.82 | DPP4 (0.39) | DPP4ERN1KDM4EMAPTNPC1 | |
| SCHEMBL16515585 | 0.82 | DPP4 (0.50) | DPP4ERN1KDM4EMAPTNPC1 | |
| SCHEMBL29419054 | 0.80 | ERN1 (0.48) | DPP4ERN1KDM4EMAPTNPC1 | |
| SCHEMBL14341162 | 0.79 | DPP4 (0.37) | DPP4ERN1KDM4EMAPTNPC1 | |
| SCHEMBL13757304 | 0.78 | HCAR2 (0.49) | DPP4KDM4EMAPTNPC1LMNA | |
| SCHEMBL10070116 | 0.76 | DPP4 (0.44) | DPP4ERN1KDM4EMAPTNPC1 | |
| SCHEMBL14341160 | 0.76 | DPP4 (0.39) | DPP4ERN1KDM4EMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8378058-B2 | Conducting polymers and uses thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2013-02-19 | — | — | US | disclosed |
| US-8378058-B2 | Conducting polymers and uses thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2013-02-19 | — | — | US | disclosed |
| US-8378058-B2 | Conducting polymers and uses thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2013-02-19 | — | — | US | disclosed |
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2009-08-27 | — | — | US | disclosed |
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2009-08-27 | — | — | US | disclosed |
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2009-08-27 | — | — | US | disclosed |
| EP-1594876-A4 | CONDUCTING POLYMERS WITH PORPHYRIN CROSS-LINKERS | UNIV WOLLONGONG (AU) | 2008-07-09 | — | — | EP | disclosed |
| US-20070295398-A1 | Conducting Polymers With Porphyrin Cross-Linkers | WOLLONGONG, UNIVERSITY OF (AU) | 2007-12-27 | — | — | US | disclosed |
| WO-2007018439-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2007-02-15 | — | — | WO | disclosed |
| WO-2007018439-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2007-02-15 | — | — | WO | disclosed |
| EP-1594876-A1 | CONDUCTING POLYMERS WITH PORPHYRIN CROSS-LINKERS | University of Wollongong (AU) | 2005-11-16 | — | — | EP | disclosed |
| WO-2004067533-A1 | CONDUCTING POLYMERS WITH PORPHYRIN CROSS-LINKERS | UNIVERSITY OF WOLLONGONG (AU) | 2004-08-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | PIN1, PPIA, PARG | DPP4 4681/4885ERN1 2632/4885KDM4E 4847/4885 |
| US-20070295398-A1 | Conducting Polymers With Porphyrin Cross-Linkers | QPCT, LCP1, QPCTL | DPP4 3662/4885ERN1 4786/4885KDM4E 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.